• Study of AGP100 Safety and Effectiveness in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

    Recruiting

    2 1 1
    Investigated Diseases:
    Norway

  • Study of anifrolumab safety in adults with primary antiphospholipid syndrome (APS)

    Recruiting

    2 1 1
    Investigated Drugs:
    Greece

  • Title: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Poland

  • A study of drug combination (clopidogrel, acetylsalicylic acid, atorvastatin, rosuvastatin) for patients with covert brain infarction

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark Norway Sweden

  • Study of cangrelor and acetylsalicylic acid in patients with ischemic stroke requiring emergency carotid artery stenting and mechanical thrombectomy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria

  • Study of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer’s disease patients

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Greece Portugal Romania Spain

  • Study of xanomeline tartrate and trospium chloride combination for cognitive impairment in people with mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Croatia Czechia Germany Greece Italy Poland +2

  • Study of KarXT (trospium chloride and xanomeline tartrate) and KarX-EC (xanomeline tartrate) for cognitive impairment in mild to moderate Alzheimer’s disease

    Recruiting

    3 1
    Investigated Drugs:
    Finland France Germany Greece Italy The Netherlands +4

  • Study of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Hungary Poland

  • Study of bevacizumab and trifluridine combination given bi-weekly to reduce severe neutropenia in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by